Form 4: Cellebrite CEO Sells Shares to Cover Tax Obligations

Cellebrite CEO Thomas E. Hogan reported the sale of 103,188 ordinary shares to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• Thomas E. Hogan, Chief Executive Officer and Director of Cellebrite DI Ltd. (CLBT), reported a disposition of 103,188 ordinary shares on July 2, 2026.
• The sale was executed to cover tax obligations arising from the vesting of restricted stock units (RSUs) granted on September 19, 2025.
• The shares were sold at a weighted average price of $15.7566, with individual transactions ranging from $15.44 to $15.97.
• Following these transactions, Mr. Hogan beneficially owns 590,777 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While insider selling can be a negative signal, the clear explanation that the sale is to cover tax obligations related to RSU vesting mitigates significant concern.

Positives

• The disposition of shares was a planned event to satisfy tax obligations, indicating responsible financial management by the CEO.
• The CEO continues to hold a significant number of shares (590,777), suggesting ongoing commitment to the company.

Negatives

• The sale of a substantial number of shares by the CEO, even if for tax purposes, could be perceived negatively by the market.
• The weighted average sale price of $15.7566 is noted, with the range indicating some price fluctuation during the sale period.

Risks

• Potential for negative market perception due to insider share sales, even if for tax reasons.
• The price range of the sales ($15.44 to $15.97) might indicate downward pressure or a lack of strong buying interest at higher prices during the transaction period.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports on a past transaction.

Management Comments

• The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

StockSavvy.ai notes that insider selling, particularly by CEOs, is a common event, often tied to personal financial planning and tax liabilities. While this transaction is for tax purposes related to RSU vesting, the market often scrutinizes such sales for any indication of management's confidence in the company's future performance.

Stakeholder Impact

• Shareholders: May interpret the sale as a negative signal, although the tax-related nature should temper this view. Continued significant beneficial ownership by the CEO remains a positive indicator.
• Employees: The CEO's actions are generally observed, but this specific transaction is unlikely to have a direct impact on employee morale or operations.
• Creditors: No direct impact expected as the transaction involves equity and personal tax obligations.
• Suppliers/Customers: No direct impact expected.

Next Steps

• The reporting person may be required to provide further details on individual sale prices upon request from the SEC, Issuer, or security holders.

Key Dates

Recommendation

This Form 4 filing reports a routine transaction by the CEO to cover tax obligations from RSU vesting. While insider selling can be a concern, the clear explanation and the CEO's substantial remaining beneficial ownership suggest this is not a reflection of diminished confidence in the company's prospects. Therefore, a 'hold' recommendation is appropriate, pending further company performance updates.

Keywords

Cellebrite, CLBT, Form 4, Insider Transaction, Share Sale, CEO, Thomas E. Hogan, Restricted Stock Units, RSU Vesting, Tax Obligations, Beneficial Ownership